Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

Share Price Information for Phoenix Group Holdings (PHNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 499.60
Bid: 499.40
Ask: 499.60
Change: -0.90 (-0.18%)
Spread: 0.20 (0.04%)
Open: 500.50
High: 501.50
Low: 498.80
Prev. Close: 500.50
PHNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

23 Aug 2018 16:46

RNS Number : 7427Y
Phoenix Group Holdings
23 August 2018
 

-NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

 

Publication of Supplementary Prospectus

Further to the publication of the Company's 2018 Interim Results earlier today, Phoenix Group Holdings ("Phoenix" or the "Company") today announces the publication of a supplementary prospectus approved by the UK Listing Authority (the "Supplementary Prospectus"), which is supplemental to and must be read in conjunction with the prospectus of the Company which was published on 30 May 2018 (the "Circular and Prospectus").

 

The Supplementary Prospectus is being published to disclose details of the Company's unaudited half-yearly interim results for the six months ended 30 June 2018 and is a requirement under the Prospectus Rules.

 

The Supplementary Prospectus and 2018 Interim Results will be made available on Phoenix's website at www.thephoenixgroup.com and will be submitted to the National Storage Mechanism, where they will be available for inspection at www.morningstar.co.uk/uk/NSM. Copies of the Supplementary Prospectus and 2018 Interim Results will also be available for inspection during normal business hours on any Business Day, free of charge, at the Company's principal place of business at Juxon House, 100 St. Paul's Churchyard, London, EC4M 8BU. 

 

Capitalised terms used in this announcement have the meanings set out in the Circular and Prospectus or the Supplementary Prospectus.

 

 

Enquiries

 

Investors/Analysts:

 

PhoenixClaire Hawkins, Head of Investor Relations+44 (0)20 3735 0575

 

HSBC (Sponsor)

Graeme Lewis, Simon Alexander, Richard Fagan

+44 (0)20 7991 8888

 

Media:

 

MaitlandAndy Donald, Vikki Kosmalska+44 (0)20 7379 5151

 

Phoenix

Shellie Wells, Head of Corporate Communications

+44 (0)20 3735 0922 / +44 (0)7872 414137

 

Important Notices

This announcement has been issued by and is the sole responsibility of the Company. This announcement is not a circular or a prospectus but an advertisement.

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for any securities in any jurisdiction. No offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities will be made in the United States, Australia, Canada, Japan or South Africa or any other jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in, and should not be distributed, forwarded to or transmitted in or into, the United States, Australia, Canada, Japan, South Africa or any other jurisdiction where to do so might constitute a violation of local securities laws or regulations.

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement, the Circular and Prospectus and the Supplementary Prospectus should not be distributed, forwarded to or transmitted in or into the United States, Australia, Canada, Japan, South Africa or any other restricted or excluded territories or any jurisdiction where to do so would be unlawful.

HSBC Bank plc, which is authorised by the Prudential Regulatory Authority ("PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority ("FCA"), is acting exclusively for the Company and for no one else in connection with the arrangements described in the Circular and Prospectus and the Supplementary Prospectus and will not regard any other person as a client in relation to the arrangements described in the Circular and Prospectus and the Supplementary Prospectus and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the arrangements referred to in the Circular and Prospectus and the Supplementary Prospectus.

No person has been authorised to give any information or to make any representations other than those contained in the Circular and Prospectus and the Supplementary Prospectus and, if given or made, such information or representations must not be relied on as having been authorised by the Company or HSBC. Subject to the Listing Rules, the Prospectus Rules and the Disclosure Guidance and Transparency Rules of the FCA, the issue of this announcement shall not, under any circumstances, create any implication that there has been no change in the affairs of the Company since the date of this announcement or that the information in it is correct as at any subsequent date.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPBUGDICXDBGIX
Date   Source Headline
28th Feb 20224:30 pmRNSTotal Voting Rights
23rd Feb 20227:00 amRNSBoard Changes
11th Feb 20225:15 pmRNSDirector/PDMR Shareholding
11th Feb 202212:00 pmRNSDirector/PDMR Shareholding
9th Feb 20229:00 amRNSDirector/PDMR Shareholding
7th Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:30 pmRNSHolding(s) in Company
31st Jan 20222:00 pmRNSTotal Voting Rights
28th Jan 20227:09 amRNSStrategic Investor Update
18th Jan 20226:00 pmRNSHolding(s) in Company
18th Jan 20226:00 pmRNSHolding(s) in Company
17th Jan 20221:00 pmRNSDirector/PDMR Shareholding
14th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
11th Jan 20225:09 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
11th Jan 20227:00 amRNS2021 Bulk Purchase Annuity Transactions
7th Jan 20222:30 pmRNSDirector/PDMR Shareholding
31st Dec 202112:00 pmRNSTotal Voting Rights
30th Dec 20214:30 pmRNSDirector/PDMR Shareholding
22nd Dec 202112:00 pmRNSChange of Auditor
20th Dec 20211:00 pmRNSBlock listing Interim Review
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
30th Nov 20212:15 pmRNSTotal Voting Rights
9th Nov 202110:15 amRNSDirector/PDMR Shareholding
1st Nov 20214:52 pmRNSArk Life Assurance Sale Completion
29th Oct 20214:30 pmRNSTotal Voting Rights
8th Oct 20219:30 amRNSDirector/PDMR Shareholding
30th Sep 20215:00 pmRNSTotal Voting Rights
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
14th Sep 20212:07 pmRNSInternal Model Harmonisation Approval
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
1st Sep 202110:00 amRNSTotal Voting Rights
25th Aug 202112:00 pmRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
16th Aug 202112:00 pmRNSDirector/PDMR Shareholding
12th Aug 20214:00 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNS2021 Half Year Results
9th Aug 20214:30 pmRNSDirector/PDMR Shareholding
30th Jul 202111:45 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSSale of Ark Life Assurance Company
8th Jul 20214:20 pmRNSDirector/PDMR Shareholding
1st Jul 20214:00 pmRNSTotal Voting Rights
29th Jun 20214:15 pmRNSHolding(s) in Company
25th Jun 20214:00 pmRNSDirector/PDMR Shareholding
24th Jun 20215:15 pmRNSBlock listing Interim Review
23rd Jun 20215:30 pmRNSPhoenix Group Holdings
23rd Jun 20217:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
23rd Jun 20217:00 amRNSStrategic Investor Update and Board Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.